From: Projecting productivity losses for cancer-related mortality 2011 – 2030
Cancer | Projected number of deaths | Value of lost paid production (million €) | Value of lost household production (million €) | Projected number of deaths (% of base case) | Value of lost paid production (million €) | Value of lost household production (million €) |
---|---|---|---|---|---|---|
Base case | 1 % Annual reduction in mortality | |||||
C18-C21: colorectal | 27,631 | 1321 | 6567 | 23,344 (84 %) | 1169 | 5765 |
C25: pancreas | 13,488 | 733 | 3355 | 11,673 (87 %) | 649 | 2947 |
C34: lung | 48,922 | 2403 | 12,493 | 41,730 (85 %) | 2124 | 10,970 |
C50: breast | 18,308 | 1255 | 7194 | 15,430 (84 %) | 1113 | 6338 |
C70-C72: brain & CNS | 6513 | 886 | 2164 | 5265 (81 %) | 786 | 1907 |
C91-C95: leukaemia | 6693 | 454 | 1691 | 5096 (76 %) | 402 | 1486 |
C00-C96: all invasive | 233,168 | 12,685 | 60,427 | 206,336 (89 %) | 11,231 | 53,086 |